marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2025-Q2
added 08-11-2025
Evolent Health DPO Ratio 2011-2025 | EVH
Annual DPO Ratio Evolent Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 27 | 35.6 | 18.2 | 26.7 | 163 | 58.2 | 103 | 106 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 163 | 18.2 | 67.3 |
Quarterly DPO Ratio Evolent Health
| 2025-Q2 | 2024-Q2 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 6.11 | - | 10.6 | - | - | - | 21.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 21.7 | 6.11 | 12.8 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Computer Programs and Systems
CPSI
|
17.8 | $ 9.25 | 4.4 % | $ 133 M |  USA |
 |
Covetrus
CVET
|
41.9 | $ 20.99 | - | $ 2.94 B | USA |
 |
NantHealth
NH
|
86.1 | $ 1.35 | -46.64 % | $ 10.4 M | USA |
 |
Cerner Corporation
CERN
|
103 | $ 94.92 | - | $ 27.9 B | USA |
 |
Castlight Health, Inc.
CSLT
|
36.1 | $ 1.4 | -7.28 % | $ 227 M | - |
 |
HMS Holdings Corp.
HMSY
|
11.7 | $ 36.975 | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
115 | $ 41.06 | - | $ 6.37 B | USA |
 |
R1 RCM
RCM
|
5.63 | $ 14.31 | - | $ 3.81 B | USA |
 |
1Life Healthcare
ONEM
|
18 | $ 16.47 | - | $ 3.37 B | USA |
 |
Signify Health
SGFY
|
57.5 | $ 30.49 | -0.02 % | $ 7.21 B | - |
 |
NextGen Healthcare
NXGN
|
14.5 | $ 23.94 | - | $ 1.6 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
22.2 | $ 10.5 | - | $ 255 M | USA |
 |
SCWorx Corp.
WORX
|
43.2 | $ 0.32 | 11.79 % | $ 467 K | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
10.9 | $ 6.81 | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
36.4 | $ 3.43 | -0.58 % | $ 51.7 M | USA |
 |
HealthStream
HSTM
|
26.3 | $ 25.83 | -0.54 % | $ 785 M | USA |
 |
GoodRx Holdings
GDRX
|
191 | $ 3.66 | -2.92 % | $ 1.41 B | USA |
 |
HealthEquity
HQY
|
47.8 | $ 95.15 | -1.06 % | $ 8.14 B | USA |
 |
Health Catalyst
HCAT
|
19.9 | $ 3.38 | -2.31 % | $ 203 M | USA |
 |
iCAD
ICAD
|
112 | $ 3.87 | - | $ 102 M | USA |
 |
American Well Corporation
AMWL
|
11.6 | $ 5.34 | -3.26 % | $ 80.1 M | USA |
 |
Omnicell
OMCL
|
27.6 | $ 29.94 | -1.96 % | $ 1.38 B | USA |
 |
Progyny
PGNY
|
171 | $ 19.23 | -1.54 % | $ 1.65 B | USA |
 |
Akerna Corp.
KERN
|
89.4 | $ 6.27 | - | $ 161 M | USA |
 |
10x Genomics
TXG
|
32.5 | $ 13.34 | -1.84 % | $ 1.56 B | USA |
 |
Zhongchao
ZCMD
|
32 | $ 0.71 | 0.28 % | $ 3.7 M |  China |
 |
OptimizeRx Corporation
OPRX
|
24.1 | $ 21.04 | 0.77 % | $ 360 M | USA |
 |
Phreesia
PHR
|
57.8 | $ 23.41 | -0.26 % | $ 1.28 B | USA |
 |
Premier
PINC
|
28.6 | $ 28.18 | 0.28 % | $ 2.32 B | USA |
 |
Accolade
ACCD
|
14.4 | $ 7.03 | 0.29 % | $ 206 M | USA |
 |
Streamline Health Solutions
STRM
|
62 | $ 5.33 | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
18.6 | $ 8.36 | -7.21 % | $ 1.43 B | USA |
 |
Schrödinger
SDGR
|
66.5 | $ 21.77 | -1.8 % | $ 1.58 B | USA |
 |
Veeva Systems
VEEV
|
19.7 | $ 291.35 | -1.42 % | $ 46.8 B | - |